| Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017 | 686 | 2017 |
| Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data L San Román, BK Menon, J Blasco, M Hernández-Pérez, A Dávalos, ... The Lancet Neurology 17 (10), 895-904, 2018 | 382 | 2018 |
| Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis … BCV Campbell, CBLM Majoie, GW Albers, BK Menon, N Yassi, G Sharma, ... The Lancet Neurology 18 (1), 46-55, 2019 | 365 | 2019 |
| Subcutaneous IGF-1 is not beneficial in 2-year ALS trial EJ Sorenson, AJ Windbank, JN Mandrekar, WR Bamlet, SH Appel, ... Neurology 71 (22), 1770-1775, 2008 | 287 | 2008 |
| Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta … BCV Campbell, WH Van Zwam, M Goyal, BK Menon, DWJ Dippel, ... The Lancet Neurology 17 (1), 47-53, 2018 | 258 | 2018 |
| Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... Muscle & nerve 60 (1), 14-24, 2019 | 216 | 2019 |
| Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial GI Wolfe, HJ Kaminski, IB Aban, G Minisman, HC Kuo, A Marx, P Ströbel, ... The Lancet Neurology 18 (3), 259-268, 2019 | 202 | 2019 |
| Consensus-based care recommendations for adults with myotonic dystrophy type 1 T Ashizawa, C Gagnon, WJ Groh, L Gutmann, NE Johnson, G Meola, ... Neurology: Clinical Practice 8 (6), 507-520, 2018 | 194 | 2018 |
| Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter WG Bradley, F Anderson, M Bromberg, L Gutmann, Y Harati, M Ross, ... Neurology 57 (3), 500-504, 2001 | 178 | 2001 |
| Admission neutrophil–lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy SD Brooks, C Spears, C Cummings, RL VanGilder, KR Stinehart, ... Journal of neurointerventional surgery 6 (8), 578-583, 2014 | 172 | 2014 |
| Resistance exercise training modulates acute gene expression during human skeletal muscle hypertrophy GA Nader, F von Walden, C Liu, J Lindvall, L Gutmann, EE Pistilli, ... Journal of applied physiology 116 (6), 693-702, 2014 | 152 | 2014 |
| Skeletal muscle gene expression in response to resistance exercise: sex specific regulation D Liu, MA Sartor, GA Nader, L Gutmann, MK Treutelaar, EE Pistilli, ... BMC genomics 11 (1), 1-14, 2010 | 138 | 2010 |
| Myokymia and neuromyotonia 2004. L Gutmann, L Gutmann Journal of neurology 251 (2), 2004 | 135 | 2004 |
| International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in … BC Jacobs, B van den Berg, C Verboon, G Chavada, DR Cornblath, ... Journal of the Peripheral Nervous System 22 (2), 68-76, 2017 | 133 | 2017 |
| Resistance training effectiveness in patients with Charcot-Marie-Tooth disease: recommendations for exercise prescription RD Chetlin, L Gutmann, M Tarnopolsky, IH Ullrich, RA Yeater Archives of physical medicine and rehabilitation 85 (8), 1217-1223, 2004 | 132 | 2004 |
| Resistance exercise training influences skeletal muscle immune activation: a microarray analysis PM Gordon, D Liu, MA Sartor, HB IglayReger, EE Pistilli, L Gutmann, ... Journal of applied physiology 112 (3), 443-453, 2012 | 130 | 2012 |
| C-reactive protein and long-term ischemic stroke prognosis RL VanGilder, DM Davidov, KR Stinehart, JD Huber, RC Turner, ... Journal of Clinical Neuroscience 21 (4), 547-553, 2014 | 127 | 2014 |
| Acute type II myofiber atrophy in critical illness L Gutmann, D Blumenthal, L Gutmann, SS Schochet Neurology 46 (3), 819-821, 1996 | 114 | 1996 |
| Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke–enhanced regimen stroke trial AM Pancioli, O Adeoye, PA Schmit, J Khoury, SR Levine, TA Tomsick, ... Stroke 44 (9), 2381-2387, 2013 | 112 | 2013 |
| When is myokymia neuromyotonia? L Gutmann, D Libell, L Gutmann Muscle & Nerve: Official Journal of the American Association of …, 2001 | 96 | 2001 |
